Genentech CEO Ashley Magargee: "Our new facility near Raleigh, North Carolina, an established biopharmaceutical talent hub, will serve as an important new setting within our manufacturing network ...

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation ...

As the administration pushes for a return to US manufacturing, outsourcing agreements with domestic manufacturers are ...

“Genentech would like to thank Governor Stein and Commerce Secretary Lilley for their support and for welcoming us to North Carolina. We are thrilled to establish this relationship with the city ...

HOLLY SPRINGS, N.C. (WTVD) -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs ...

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States amid ...

Global life sciences leader to invest $700 million in Holly Springs, North Carolina, creating 400 jobs Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers ...

North Carolina Gov. Josh Stein announced that Genentech, a biotechnology company, will build a new manufacturing plant in Wake County, creating 420 jobs. Speaking at the SelectUSA Investment ...

“I’m proud that Genentech has chosen North Carolina for its first facility on the East Coast,” added Josh Stein, governor of NC. “This major investment in Holly Springs shows that our ...

(RTTNews) - Genentech announced plans to invest more than $700 million in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, NC. The project will add more ...